Paper33468698
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S and 9 others. mBio, 2021. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody. Papers, record 33468698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33468698
- Disease
- cervical intraepithelial neoplasia38 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Human papillomavirus 16 | Major topic |
| Human papillomavirus 18 | Major topic |
| Papillomavirus Infections | Major topic |
| Papillomavirus Vaccines | Major topic |
| Uterine Cervical Neoplasms | Major topic |
| Vaccines, DNA | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Bacterial Proteins | |
| DNA-Binding Proteins | |
| Female | |
| HSP70 Heat-Shock Proteins | |
| Humans | |
| Immunization, Secondary | |
| Mice | |
| Mice, Inbred C57BL | |
| Oncogene Proteins, Viral | |
| Papillomavirus E7 Proteins | |
| Programmed Cell Death 1 Receptor | |
| Protein Engineering | |
| Recombinant Fusion Proteins | |
| Repressor Proteins | |
| Survival Analysis | |
| Vaccination | |
| Vaccinia virus |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 CA098252 | NCI NIH HHS | United States | P50CA098252 | PubMed and NIH | NIH RePORTER |
| R01 CA233486 | NCI NIH HHS | United States | R01CA233486 | PubMed and NIH | NIH RePORTER |
| R01 CA237067 | NCI NIH HHS | United States | R01CA237067 | PubMed | NIH RePORTER |
| R01 GM136711 | NIGMS NIH HHS | United States | R01GM136711 | PubMed | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00788164 | Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia | Derived from the trial | Yes |
Source ClinicalTrials.gov
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8794328 | Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. | J Virol | 1996 | https://conductscience.org/library/papers/8794328 | PubMed |
| 2 | 12883527 | CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination. | Gene Ther | 2003 | https://conductscience.org/library/papers/12883527 | PubMed |
| 3 | 24812273 | Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors. | Cancer Res | 2014 | https://conductscience.org/library/papers/24812273 | PubMed |
| 4 | 11257391 | Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. | Vaccine | 2001 | https://conductscience.org/library/papers/11257391 | PubMed |
| 5 | 30350310 | Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. | Int J Cancer | 2019 | https://conductscience.org/library/papers/30350310 | PubMed |
| 6 | 30296681 | Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination. | Virology | 2018 | https://conductscience.org/library/papers/30296681 | PubMed |
| 7 | 10451482 | Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. | J Pathol | 1999 | https://conductscience.org/library/papers/10451482 | PubMed |
| 8 | 16353149 | Definition of an HPV18/45 cross-reactive human T-cell epitope after DNA immunisation of HLA-A2/KB transgenic mice. | Int J Cancer | 2006 | https://conductscience.org/library/papers/16353149 | PubMed |
| 9 | 10523825 | Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. | Oncogene | 1999 | https://conductscience.org/library/papers/10523825 | PubMed |
| 10 | 8617242 | The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors. | EMBO J | 1996 | https://conductscience.org/library/papers/8617242 | PubMed |
| 11 | 32695664 | High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions. | Front Oncol | 2020 | https://conductscience.org/library/papers/32695664 | PubMed |
| 12 | 19118066 | A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19118066 | PubMed |
| 13 | 10822298 | Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. | Gene Ther | 2000 | https://conductscience.org/library/papers/10822298 | PubMed |
| 14 | 8208532 | Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. | Oncogene | 1994 | https://conductscience.org/library/papers/8208532 | PubMed |
| 15 | 14985791 | Comparison of HPV DNA vaccines employing intracellular targeting strategies. | Gene Ther | 2004 | https://conductscience.org/library/papers/14985791 | PubMed |
| 16 | 28368072 | Review of HPV-related diseases and cancers. | New Microbiol | 2017 | https://conductscience.org/library/papers/28368072 | PubMed |
| 17 | 25752814 | Human papillomavirus molecular biology and disease association. | Rev Med Virol | 2015 | https://conductscience.org/library/papers/25752814 | PubMed |
| 18 | 18781156 | DNA vaccines: ready for prime time? | Nat Rev Genet | 2008 | https://conductscience.org/library/papers/18781156 | PubMed |
| 19 | 10201889 | Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. | J Immunol | 1999 | https://conductscience.org/library/papers/10201889 | PubMed |
| 20 | 26403783 | Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers. | Mod Pathol | 2015 | https://conductscience.org/library/papers/26403783 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930118 | Integrated Microfluidic CRISPR-Based Diagnostic Device for Rapid Testing of HPVs. | Biosensors (Basel) | 2026 | https://conductscience.org/library/papers/42930118 | PubMed |
| 42883212 | Heterologous Antigen Regimen and Bicistronic DNA Vaccination Targeting HPV16 E5 and E7 Oncoproteins: Immunoinformatics and Preclinical Antitumor Efficacy. | Molecules | 2026 | https://conductscience.org/library/papers/42883212 | PubMed |
| 42643979 | A Cell-Penetrating Peptide and Signal Sequence Fusion DNA Vaccine Enhances CD8+ T Cell-Mediated Anti-Tumor Immunity Targeting HPV-16 Cervical Cancer Antigens. | Obstet Gynecol Res | 2026 | https://conductscience.org/library/papers/42643979 | PubMed |
| 42568545 | Circular RNAs in cervical cancer: from ceRNA networks to epitranscriptomic regulation, immune modulation, and metastatic reprogramming. | Front Immunol | 2026 | https://conductscience.org/library/papers/42568545 | PubMed |
| 42523483 | Stepwise Enhancement of HPV16 E6/E7 mRNA Vaccine Efficacy Using HSV-1 gD Epitope Incorporation and Immune-Modulating Agents. | Res Sq | 2026 | https://conductscience.org/library/papers/42523483 | PubMed |
| 42519393 | Oncolytic virus-mediated remodeling of tumor microenvironment enhances efficacy of an HPV16 E6/E7 mRNA vaccine in an HPV-positive tumor. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42519393 | PubMed |
| 42449784 | Development of a Double-Antibody Sandwich ELISA for the Detection of HPV16 E6 Protein. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42449784 | PubMed |
| 42400858 | A low-dose self-amplifying mRNA vaccine encoding HPV16 E6/E7 induces potent T-cell immunity and antitumor protection in mice. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/42400858 | PubMed |
| 42125658 | Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42125658 | PubMed |
| 42079630 | A novel mRNA-based therapeutic vaccine elicits robust anti-tumor immunity against HPV-associated malignancies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42079630 | PubMed |
| 41776327 | The clinical application value of dynamic monitoring of HPV ctDNA in concurrent chemoradiotherapy for locally advanced cervical cancer. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/41776327 | PubMed |
| 41084861 | Recombinant lactococcus lactis expressing HPV-16 E6E7 dual antigens for potential cervical cancer treatment enhances dendritic cell vaccines efficacy. | Future Microbiol | 2025 | https://conductscience.org/library/papers/41084861 | PubMed |
| 41012179 | Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012179 | PubMed |
| 40479650 | Membrane-IL12 adjuvant mRNA vaccine polarizes pre-effector T cells for optimized tumor control. | J Exp Med | 2025 | https://conductscience.org/library/papers/40479650 | PubMed |
| 40336572 | Genetic adjuvants: A paradigm shift in vaccine development and immune modulation. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/40336572 | PubMed |
| 40316302 | Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40316302 | PubMed |
| 40283217 | Expression of 9-O-Acetylated Sialic Acid in HPV+ Oral Squamous Cell Carcinoma Cells. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40283217 | PubMed |
| 40282913 | Evaluation of the Efficacy of Active Hexose Correlated Compound as an Adjuvant in Reducing Recurrence After Condyloma Cauterization. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40282913 | PubMed |
| 40007779 | Unraveling HPV-associated cancer complexity: From molecular insights to innovative therapies. | Heliyon | 2025 | https://conductscience.org/library/papers/40007779 | PubMed |
| 39991713 | Systematic collection, annotation, and pattern analysis of viral vaccines in the VIOLIN vaccine knowledgebase. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/39991713 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| IMIQUIMOD | CHEMBL1282 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1282 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33468698
GET https://conductscience.org/api/papers/v1/33468698/references?page=2